Skip to content

Scientific Newsletter

Cure HHT’s biannual newsletter that, based on the importance of each study, centralizes and summarizes select publications about HHT for patients, clinicians, and scientists.

Related News

A Monumental $128 Million Step Forward for HHT Research

Today is a monumental day for HHT. The new biotechnology company, Diagonal Therapeutics, officially launched and we wanted to share more about why this is news you simply can’t miss! In short, Diagona…

Scroll To Top